Keywords : Uropathogenic &amp; Escherichia Coli
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 3, Pages 4914-4919
Background & Method: The study is conducted with an aim to study Antibiotic resistance among Uropathogenic Escherichia Coli, targeted both male and female outpatients and inpatients presenting with symptoms and signs of UTI which include dysuria, polyuria, fever, nausea, and flank pain were sampled for this study. This study is done with an aim to study Antibiotic resistance among Uropathogenic Escherichia Coli. Baseline demographic data including age, sex, level of education and risk factors such as catheterization, history of UTI, also out and in patients were also collected.
Result: Among the total 120 isolates, resistant to ≥2 drugs were recorded in 108 (90 %) of all uropathogens. Seventy seven (93.9 %) isolates of Gram-negative bacteria and 31(81.6 %) of Gram positive bacteria showed resistance to two or more drugs (Table 4). Resistance pattern of bacterial isolates to more than two antibiotics of patients (N = 120)
Conclusion: There is a need for continuous surveillance of antibiotic to the currently used antibiotics in management of urinary tract infections covering the entire Index Hospital . Index Hospital to enforce policies formulated by pharmacy and poison board to prevent misuse or underuse of antibiotics by giving prescription to only patients with results of culture and sensitivity and therefore treatment UTIs should be based on and sensitivity in order to limit multidrug resistance. Continuous follow up to provide an update of laboratory diagnosis of urinary tract infections in order to reduce multidrug resistance bacteria in UTI patients. Health care workers should enforce health education to patients in order to adhere to the treatment and thereby reducing drug resistance. v) Screening for resistance and identify modes of transmission.